Revelation announces Phase 1 study of Gemini met primary safety endpoint
PremiumThe FlyRevelation announces Phase 1 study of Gemini met primary safety endpoint
4M ago
Revelation Biosciences completes enrollment in Gemini study
Premium
The Fly
Revelation Biosciences completes enrollment in Gemini study
5M ago
Revelation Biosciences reports Q1 EPS ($2.46), consensus ($5.38)
Premium
The Fly
Revelation Biosciences reports Q1 EPS ($2.46), consensus ($5.38)
6M ago
Revelation Biosciences Secures $6.2M in Public Offering
PremiumCompany AnnouncementsRevelation Biosciences Secures $6.2M in Public Offering
9M ago
Revelation Biosciences 1.365M share IPO priced at $4.53
Premium
The Fly
Revelation Biosciences 1.365M share IPO priced at $4.53
9M ago
Revelation Biosciences Inc trading resumes
Premium
The Fly
Revelation Biosciences Inc trading resumes
9M ago
Revelation Biosciences Inc trading halted, news pending
PremiumThe FlyRevelation Biosciences Inc trading halted, news pending
10M ago
Revelation Biosciences announces 1-for-30 reverse split, effective Jan 25
Premium
The Fly
Revelation Biosciences announces 1-for-30 reverse split, effective Jan 25
10M ago
Revelation Biosciences reports Q3 EPS (42c), consensus (30c)
Premium
The Fly
Revelation Biosciences reports Q3 EPS (42c), consensus (30c)
12M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100